Abstract

Background and AimsThere are few studies on non-obese fatty liver disease, the aims of this study was to analyze its prevalence, popular trends, and associated and predictive factors, so as to provide reference for its prevention and treatment.MethodsIndividuals with complete data of body mass index, sex, age, and abdominal ultrasound in Karamay Central Hospital from 2009 to 2016 were selected to analyze the prevalence and popular trends of non-obese fatty liver disease (body mass index <24 kg/m2), and associated and predictive factors.ResultsBetween 2009 and 2016, a total of 191,555 medical check-ups were included. The prevalence of non-obese fatty liver disease increased from 1.9% to 5.1% among general medical examinants (P<0.001), increased from 4.6% to 11.7% in non-obese individuals (P<0.001). Compared with the non-obese control group, the levels of age, body mass index, blood pressure, fasting blood glucose, triglycerides, total cholesterol and uric acid in the non-obese fatty liver group were higher (P<0. 05). Even among non-obese subjects, elevated body mass index was associated with a 0.63-fold increased risk for non-obese fatty liver disease (P<0.001, odds ratio=1.63, 95% confidence interval 1.54-1.72) for every one-unit increase in body mass index. The most common abnormal indicator of non-obese fatty liver disease was elevated triglycerides (44.2%), which was also the best predictor of non-obese fatty liver disease (area under the curve =0.795) in non-obese physical examinators.ConclusionsThe prevalence of non-obese fatty liver disease was high and increasing rapidly in Karamay. Triglycerides is the best predictor of non-obese fatty liver in non-obese physical examinators.

Highlights

  • In the past decade, the prevalence of fatty liver disease (FLD) has increased significantly [1,2,3]

  • The prevalence of non-obese FLD increased from 1.9% to 5.1%, showing a 1.7-fold increase (P

  • Prevalence increased from 1.9% to 5.4% in males and from 1.8% to 4.8% in females

Read more

Summary

Introduction

The prevalence of fatty liver disease (FLD) has increased significantly [1,2,3]. Some of the few existing relevant studies are mostly metaanalyses based on the general population, providing a good picture of the global distribution of non-obese FLD [8, 9]. These studies did not provide the popular trends of non-obese FLD, nor did they propose how to screen it from a large number of people by simple indicators. There are few studies on non-obese fatty liver disease, the aims of this study was to analyze its prevalence, popular trends, and associated and predictive factors, so as to provide reference for its prevention and treatment

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call